This report on hyaluronic acid products market studies various product types and applications. Hyaluronic acid products adds value to cell permeability and cell proliferation and considered as an vital constituent of the extracellular matrix. Hyaluronic acid products has extensive number of applications such as orthopedic surgery, rheumatology, ophthalmology, otolaryngology, dermatology and plastic surgery, wound healing and drug delivery. On a similar grounds, it is also available in various dosage forms according to its applications e.g. in osteoarthritis treatment HA injections are available to inject it in the synovial cavity. The market for hyaluronic acid products is anticipated to experience tremendous growth worldwide, mainly due to factors such as aging population, increasing patient awareness related to hyaluronic acid products, obesity leading to orthopedic diseases and high demand for minimally-invasive procedures.

For the purpose of this study, the global hyaluronic acid products market on the basis of product type is segmented into single injection, three- cycle injection and five-cycle injection. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

On the basis of application type global hyaluronic acid products market is segmented as vesicoureteral reflux, dermal fillers, ophthalmic and osteoarthritis. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

The hyaluronic acid products market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2013 to 2022 and their CAGRs for the period 2016 to 2022 are provided in this report.

The major key players profiled in the hyaluronic acid products market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Anika Therapeutics, Inc., Allergan, Inc., Sanofi S.A., Ferring B.V., Seikagaku Corporation, Salix Pharmaceutical, Fidia Farmaceutici, Zimmer Biomet.

Based on the type of product, the global hyaluronic acid products market is segmented as follows:

• Single Injection
• Three-Injection Cycle
• Five-Injection Cycle

Hyaluronic acid products, also known as hyaluronan or HA, are organic compounds which belong to the branch of carbohydrates and further to its polysaccharides segment. HA is prepared in laboratory by various processes which include extraction from rooster combs, in-vitro and bacterial production. It is a non-sulphated glycosaminoglycan which is present in the connective, neural and epithelial tissues of living organisms. Owing to its hydrophilic nature, hyaluronic acid products is used as lubricants and shock absorbers in various joint disorders, including osteoarthritis. On the basis of product type the global hyaluronic acid products market can be segmented into: single injection, three injection and five injections regimen. The five injection regimen held the largest share in the global hyaluronic acid products market. However, the single injection regimen is expected to grow at a faster rate as compared to the other regimens due to the shifting patient preferences towards the shorter regimen over longer regimen owing to low risk of side effects.

Based on the type of application, the hyaluronic acid products market is segmented into:

• Osteoarthritis
• Ophthalmic
• Dermal Fillers
• Vesicoureteral Reflux

Hyaluronic acid products forms naturally throughout the human body. Several trials have been conducted to explore the beneficial properties of hyaluronic acid products in the field of orthopedics, aesthetics, ophthalmology and others. Hyaluronic acid products can be modified into different forms such as viscoelastic solutions, non-woven meshes, electrospun fibers, soft and stiff hydrogels, flexible sheets, non-particulate fluids and fibrillar sponges. Unique viscoelastic properties off hyaluronic acid products and its non-immunogenicity and biocompatibility have led to its adoption in several clinical applications such as in eye surgery, supplementation of joint fluid, healing of surgical wounds and cosmetic procedures.

In 2013, the World Health Organization (WHO) estimated that 9.8% of the world’s population over 60 years old suffers from osteoarthritis; 80% of people with osteoarthritis experience limitation of movement; and 24.7% cannot perform daily activities. Thus, with rising incidences of osteoarthritis, a common disorder observed in old-aged and middle aged population due to obesity and changing lifestyle, the demand for these products in osteoarthritis application is expected to grow at a CAGR of 9.0% during the study period. Rising obesity in geriatric patients is the major reason for peaking osteoarthritis prevalence. In 2014, according to WHO, in total worldwide population suffering from osteoarthritis around 30% – 35% of the patients suffer from knee osteoarthritis. Hence, market potential for hyaluronic acid products specific to osteoarthritis application have significant throughout the forecast period.

For the purpose of this study, the global hyaluronic acid products market is categorized into:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

In base year 2015, North America was observed as the leading geographical region in hyaluronic acid products market due to rising application and demand as dermal filler and intra-articular injections in osteoarthritis are the key factors assisting the growth of hyaluronic acid products market. Since the last decade, efforts of industry players and modern technology have helped in expansion of hyaluronic acid products’ application area (such as osteoarthritis, dermal fillers, ophthalmic surgery and vesicoureteral reflux), wide range of dosage forms (such as injections, creams, lotions and others) and high safety. Premium price ranged single-injection products and injections used in vesicoureteral reflux (VUR) have been introduced in North American and European markets, while Asia-Pacific and RoW remain untapped. However, the hyaluronic acid products has successfully recovered and increased the level of acceptance in patients for fillers which were earlier decreased due to serious side-effects observed in Botox. Asia-Pacific and Latin America were observed to be the emerging and most attractive markets for hyaluronic acid products and Asia-Pacific is estimated to be the fastest growing market driven by economic development, rising demand for cosmetic surgeries, developing plastic surgery facilities and high demand for minimally invasive surgeries. Thus, due to all the above mentioned factors, Asia-Pacific is expected to grow at the highest CAGR of 9.4% during the forecast period 2016 to 2022.